Anti-REEP2 monoclonal antibody

Pre-made anti-REEP2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to REEP2/REEP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1479-Ab-1/ GM-Tg-hg-IP1479-Ab-2Anti-Human REEP2 monoclonal antibodyHuman
GM-Tg-rg-IP1479-Ab-1/ GM-Tg-rg-IP1479-Ab-2Anti-Rat REEP2 monoclonal antibodyRat
GM-Tg-mg-IP1479-Ab-1/ GM-Tg-mg-IP1479-Ab-2Anti-Mouse REEP2 monoclonal antibodyMouse
GM-Tg-cynog-IP1479-Ab-1/ GM-Tg-cynog-IP1479-Ab-2Anti-Cynomolgus/ Rhesus macaque REEP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1479-Ab-1/ GM-Tg-felg-IP1479-Ab-2Anti-Feline REEP2 monoclonal antibodyFeline
GM-Tg-cang-IP1479-Ab-1/ GM-Tg-cang-IP1479-Ab-2Anti-Canine REEP2 monoclonal antibodyCanine
GM-Tg-bovg-IP1479-Ab-1/ GM-Tg-bovg-IP1479-Ab-2Anti-Bovine REEP2 monoclonal antibodyBovine
GM-Tg-equg-IP1479-Ab-1/ GM-Tg-equg-IP1479-Ab-2Anti-Equine REEP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1479-Ab-1/ GM-Tg-hg-IP1479-Ab-2; GM-Tg-rg-IP1479-Ab-1/ GM-Tg-rg-IP1479-Ab-2;
GM-Tg-mg-IP1479-Ab-1/ GM-Tg-mg-IP1479-Ab-2; GM-Tg-cynog-IP1479-Ab-1/ GM-Tg-cynog-IP1479-Ab-2;
GM-Tg-felg-IP1479-Ab-1/ GM-Tg-felg-IP1479-Ab-2; GM-Tg-cang-IP1479-Ab-1/ GM-Tg-cang-IP1479-Ab-2;
GM-Tg-bovg-IP1479-Ab-1/ GM-Tg-bovg-IP1479-Ab-2; GM-Tg-equg-IP1479-Ab-1/ GM-Tg-equg-IP1479-Ab-2
Products NameAnti-REEP2 monoclonal antibody
Formatmab
Target NameREEP2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-REEP2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1479-Ag-1Recombinant multi-species REEP2/ C5orf19/ SGC32445 protein


    Target information

    Target IDGM-IP1479
    Target NameREEP2
    Gene ID51308,225362,682105,716686,100683708,105260695,532432,100062247
    Gene Symbol and SynonymsC5orf19,REEP2,SGC32445,SPG72,Yip2d
    Uniprot AccessionQ9BRK0,Q2KI30
    Uniprot Entry NameREEP2_HUMAN,REEP2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000132563
    Target ClassificationN/A

    The target: REEP2, gene name: REEP2, also named as C5orf19, SGC32445, SPG72, Yip2d. This gene encodes a member of the receptor expression enhancing protein family. Studies of a related gene in mouse suggest that the encoded protein is found in the cell membrane and enhances the function of sweet taste receptors. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.